Associations of perfluorinated chemical serum concentrations and biomarkers of liver function and uric acid in the US population (NHANES), 2007-2010

Environmental Research

Volumn 136, Issue , 2015, Pages 8-14

  Gleason, Jessie A ^a   Post, Gloria B ^b   Fagliano, Jerald A ^a  

^a NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^b NEW JERSEY DEPARTMENT OF ENVIRONMENTAL PROTECTION   (United States)

Author keywords

Liver function; NHANES; Perfluorochemicals; Uric acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; MALATHION; PERFLUORO COMPOUND; PHOSPHATE; TRANSFERASE; URIC ACID; FLUOROCARBON;

BIOMARKER; CONCENTRATION (COMPOSITION); ENZYME ACTIVITY; ORGANIC COMPOUND; POPULATION STRUCTURE; SERUM;

ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD LEVEL; BODY MASS; ETHNICITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; HEALTH SURVEY; HUMAN; LIVER FUNCTION; POVERTY; PUBLIC HEALTH; RACE; SMOKING; STATISTICAL SIGNIFICANCE; UNITED STATES; URIC ACID BLOOD LEVEL; BLOOD; NUTRITION;

UNITED STATES;

BIOLOGICAL MARKERS; FLUOROCARBONS; HUMANS; NUTRITION SURVEYS; UNITED STATES; URIC ACID;

EID: 84911058879     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2014.10.004     Document Type: Article

References (40)

1. 3M, 2013. 3M's Phase Out and New Technologies.
2. Barry V., et al. Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ. Health Perspect. 2013, 121:1313-1318.
3. Buck R.C., et al. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integr. Environ. Assess. Manag. 2011, 7:513-541.
4. Butenhoff J.L., et al. Evaluation of potential reproductive and developmental toxicity of potassium perfluorohexanesulfonate in Sprague Dawley rats. Reprod. Toxicol. 2009, 27:331-341.
5. Calafat A.M., et al. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ. Health Perspect. 2007, 115:1596-1602.
6. Costa G., et al. Thirty years of medical surveillance in perfluooctanoic acid production workers. J. Occup. Environ. Med. 2009, 51:364-372.
7. Davis K.L., et al. Transport of ammonium perfluorooctanoate in environmental media near a fluoropolymer manufacturing facility. Chemosphere 2007, 67:2011-2019.
8. Emmett E.A., et al. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J. Occup. Environ. Med. 2006, 48:759-770.
9. Emmett E.A., et al. Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. J. Occup. Environ. Med. 2006, 48:771-779.
10. Gallo V., et al. Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure. Environ. Health Perspect. 2012, 120:655-660.
11. Geiger S.D., et al. Positive association between perfluoroalkyl chemicals and hyperuricemia in children. Am. J. Epidemiol. 2013, 177:1255-1262.
12. Gilliland F.D., Mandel J.S. Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: a study of occupationally exposed men. Am. J. Ind. Med. 1996, 29:560-568.
13. Glantzounis G.K., et al. Uric acid and oxidative stress. Curr. Pharm. Des. 2005, 11:4145-4151.
14. Han X., et al. Uptake of perfluorooctanoate in freshly isolated hepatocytes from male and female rats. Toxicol. Lett. 2008, 181:81-86.
15. Johnson C., et al. National Health and Nutrition Examination Survey: Analytic Guidelines, 1999-2010 2013, vol. 2. National Center for Health Statistics, Washington, DC.
16. Kato K., et al. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999-2008. Environ. Sci. Technol. 2011, 45:8037-8045.
17. Lau C. Perfluorinated compounds. EXS 2012, 101:47-86.
18. Lau C., et al. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99:366-394.
19. Lin C.Y., et al. Investigation of the associations between low-dose serum perfluorinated chemicals and liver enzymes in US adults. Am. J. Gastroenterol. 2010, 105:1354-1363.
20. Lin C.Y., et al. Association between levels of serum perfluorooctane sulfate and carotid artery intima-media thickness in adolescents and young adults. Int. J. Cardiol. 2013, 168:3309-3316.
21. Lindstrom A.B., et al. Polyfluorinated compounds: past, present, and future. Environ. Sci. Technol. 2011, 45:7954-7961.
22. Mellen P.B., et al. Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension 2006, 48:1037-1042.
23. Mundt D.J., et al. Clinical epidemiological study of employees exposed to surfactant blend containing perfluorononanoic acid. Occup. Environ. Med. 2007, 64:589-594.
24. Ndrepepa G., et al. A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease. Nutr. Metab. Cardiovasc. Dis. 2013, 23:1195-1201.
25. Olsen G.W., et al. Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug Chem. Toxicol. 2000, 23:603-620.
26. Olsen G.W., et al. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J. Occup. Environ. Med. 2003, 45:260-270.
27. Olsen G.W., Zobel L.R. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int. Arch. Occup. Environ. Health 2007, 81:231-246.
28. Post G.B., et al. Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature. Environ. Res. 2012, 116:93-117.
29. Post G.B., et al. Occurrence of perfluorinated compounds in raw water from New Jersey public drinking water systems. Environ. Sci. Technol. 2013, 47:13266-13275.
30. Rosen M.B., et al. Gene expression profiling in wild-type and PPARalpha-null mice exposed to perfluorooctane sulfonate reveals PPARalpha-independent effects. PPAR Res. 2010, 2010.
31. Sakr C.J., et al. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J. Occup. Environ. Med. 2007, 49:1086-1096.
32. Sakr C.J., et al. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J. Occup. Environ. Med. 2007, 49:872-879.
33. SAS, 2002-2008. Statistical Analysis Software (SAS) Institute Inc. Cary, NC.
34. Shankar A., et al. Perfluoroalkyl chemicals and elevated serum uric acid in US adults. Clin. Epidemiol. 2011, 3:251-258.
35. Steenland K., et al. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. Environ. Health Perspect. 2010, 118:229-233.
36. USEPA 2010/2015 PFOA Stewardship Program 2013, Environmental Protection Agency, Office of Pollution Prevention and Toxics, Washington, DC.
37. Vaalgamaa S., et al. Photochemical reactivity of perfluorooctanoic acid (PFOA) in conditions representing surface water. Sci. Total Environ. 2011, 409:3043-3048.
38. Weiner D.E., et al. Uric acid and incident kidney disease in the community. J. Am. Soc. Nephrol. 2008, 19:1204-1211.
39. Wolf C.J., et al. Developmental effects of perfluorononanoic acid in the mouse are dependent on peroxisome proliferator-activated receptor-alpha. PPAR Res. 2010, 2010.
40. Zoccali C., Mallamaci F. Uric acid, hypertension, and cardiovascular and renal complications. Curr. Hypertens. Rep. 2013, 15:531-537.